Harry Chingon
Psychiatry · Aiea, HINPI 1942242854
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 908 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 908 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Alkermes, Inc.$1K
- plus $4K from 12 others
What the payments were for
- Food & beverage$15,327100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 139 | $2,499 |
| Takeda Pharmaceuticals U.S.A., Inc. | 192 | $2,451 |
| AbbVie(2 entities) | 112 | $1,949 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 69 | $1,499 |
| Otsuka America Pharmaceutical, Inc. | 78 | $1,497 |
| Alkermes, Inc. | 77 | $1,267 |
| Lundbeck LLC | 93 | $1,222 |
| Neurocrine Biosciences, Inc. | 35 | $774 |
| E.r. Squibb & Sons, L.L.C. | 13 | $431 |
| Johnson & Johnson | 33 | $427 |
| Indivior Inc. | 28 | $411 |
| Axsome Therapeutics, Inc. | 13 | $275 |
| Vanda Pharmaceuticals Inc. | 12 | $250 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $133 |
| Teva Pharmaceuticals USA, Inc. | 4 | $91 |
| Eisai Inc. | 4 | $72 |
| Avanir Pharmaceuticals, Inc. | 3 | $55 |
| Acadia Pharmaceuticals Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,327 in reported general payments places this provider in the 95th percentile of 183 psychiatry providers in Hawaii.
Other psychiatry in Aiea
- Michael ZafraniAiea$29K
- Jon CooneyAiea$21K
- Noelle YuenAiea$1K
- Elena SharipovaAiea$601
- Denis Mee-LeeHonolulu$526K
- David SteinHonolulu$186K
- Edward WuKaneohe$13K
- Peter YamamotoWaianae$13K
- Gregory YuenHonolulu$6K
- Raymond DavidsonHonolulu$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.